These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37035854)

  • 21. Outbreak of COVID-19: A Detailed Overview and Its Consequences.
    Shivalkar S; Pingali MS; Verma A; Singh A; Singh V; Paital B; Das D; Varadwaj PK; Samanta SK
    Adv Exp Med Biol; 2021; 1353():23-45. PubMed ID: 35137366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries.
    Elshabrawy HA
    Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32585913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Broad-Spectrum Antiviral Peptides and Polymers.
    Kuroki A; Tay J; Lee GH; Yang YY
    Adv Healthc Mater; 2021 Dec; 10(23):e2101113. PubMed ID: 34599850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses.
    Tse LV; Meganck RM; Graham RL; Baric RS
    Front Microbiol; 2020; 11():658. PubMed ID: 32390971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fusion Protein Targeted Antiviral Peptides: Fragment-Based Drug Design (FBDD) Guided Rational Design of Dipeptides Against SARS-CoV-2.
    Manna S; Chowdhury T; Baindara P; Mandal SM
    Curr Protein Pept Sci; 2020; 21(10):938-947. PubMed ID: 32901582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19: A Worldwide, Zoonotic, Pandemic Outbreak.
    Khan T; Agnihotri K; Tripathi A; Mukherjee S; Agnihotri N; Gupta G
    Altern Ther Health Med; 2020 Aug; 26(S2):56-64. PubMed ID: 32412918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery.
    Chellapandi P; Saranya S
    Med Chem Res; 2020; 29(10):1777-1791. PubMed ID: 32837137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
    Krishna G; Pillai VS; Veettil MV
    Eur J Pharmacol; 2020 Oct; 885():173450. PubMed ID: 32739174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment.
    Taibe NS; Kord MA; Badawy MA; Shytaj IL; Elhefnawi MM
    Ther Adv Respir Dis; 2022; 16():17534666221132736. PubMed ID: 36282077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
    Dinda B; Dinda S; Dinda M
    Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery.
    Essa RZ; Wu YS; Batumalaie K; Sekar M; Poh CL
    Pharmacol Rep; 2022 Dec; 74(6):1166-1181. PubMed ID: 36401119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging strategies on in silico drug development against COVID-19: challenges and opportunities.
    Yadav M; Dhagat S; Eswari JS
    Eur J Pharm Sci; 2020 Dec; 155():105522. PubMed ID: 32827661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Applications of separation technology in novel coronavirus research, epidemic prevention and detection].
    Li L; Zhu C; Zhao X; Qu F
    Se Pu; 2021 Jul; 39(7):679-685. PubMed ID: 34227364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of Traditional Chinese Medicine and Systems Pharmacology in Drug Prevention and Treatment against COVID-19.
    Zhou W; Chen Z; Sun X; Zhong N; Liu Z
    Am J Chin Med; 2021; 49(5):1045-1061. PubMed ID: 34225580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review on
    Cetin Y; Aydinlik S; Gungor A; Kan T; Avsar T; Durdagi S
    Curr Med Chem; 2022; 29(38):5925-5948. PubMed ID: 35761502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Searching for effective antiviral small molecules against influenza A virus: A patent review.
    Ginex T; Luque FJ
    Expert Opin Ther Pat; 2021 Jan; 31(1):53-66. PubMed ID: 33012213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.